Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Who could’ve guessed ...

This study is Pew Research Center’s latest effort to explore the landscape of teens and technology today. It focuses on artificial intelligence – from how teens use chatbots to how they think about AI ...

When new technology lands in children’s hands, they don’t read the manual. And they don’t tell their parents. They push every button, test every limit and try to break it. It’s how kids learn. And ...

When it comes to their federal income tax returns, tens of millions of US households pay for tax preparation and filing. Yet many might qualify to do so for free through IRS-approved programs. So why ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

If you’ve ever dealt with a stuffy nose that just won’t quit – whether from allergies, a lingering cold or dry winter air – you’ve probably been tempted to try anything for relief. Enter the neti pot: ...

Some college programs whose graduates earn less than workers with only a high school diploma could lose access to federal student loans under the Republicans' "big, beautiful bill" act, a change that ...

Add Yahoo as a preferred source to see more of our stories on Google. The Trump administration is promoting a new drug program it says will will reduce costs for Americans: TrumpRx. The initiative ...

Agents use facial recognition, social media monitoring and other tech tools not only to identify undocumented immigrants but also to track protesters, current and former officials said. By Sheera ...

The H-2A program continues to grow, with 13,358 more positions certified in fiscal year 2025 (October 2024-September 2025) than fiscal year 2024. This marks the first year in program history that over ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...